Analysis of Recurrent Malignant Glioma : Pipeline Review, Technology, Applications, Growth and Status 2017

ResearchMoz presents professional and in-depth study of "Recurrent Malignant Glioma - Pipeline Review, H1 2015".

Global Markets Directs, Recurrent Malignant Glioma Pipeline Review, H1 2015, provides an overview of the Recurrent Malignant Gliomas therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Recurrent Malignant Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Recurrent Malignant Glioma and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

    The report provides a snapshot of the global therapeutic landscape of Recurrent Malignant Glioma
    The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
    The report reviews key players involved in the therapeutics development for Recurrent Malignant Glioma and enlists all their major and minor projects

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=244783

    The report summarizes all the dormant and discontinued pipeline projects
    A review of the Recurrent Malignant Glioma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
    Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
    A detailed assessment of monotherapy and combination therapy pipeline projects
    Coverage of the Recurrent Malignant Glioma pipeline on the basis of target, MoA, route of administration and molecule type
    Latest news and deals relating related to pipeline products
 
Table of Contents

List of Tables 4
List of Figures 4

Introduction 5
Global Markets Direct Report Coverage 5
Recurrent Malignant Glioma Overview 6
Therapeutics Development 7
Pipeline Products for Recurrent Malignant Glioma - Overview 7
Pipeline Products for Recurrent Malignant Glioma - Comparative Analysis 8
Recurrent Malignant Glioma - Therapeutics under Development by Companies 9
Recurrent Malignant Glioma - Therapeutics under Investigation by Universities/Institutes 10
Recurrent Malignant Glioma - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Recurrent Malignant Glioma - Products under Development by Companies 13
Recurrent Malignant Glioma - Products under Investigation by Universities/Institutes 14
Recurrent Malignant Glioma - Companies Involved in Therapeutics Development 15
Amgen Inc. 15

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=244783

AstraZeneca PLC 16
Eisai Co., Ltd. 17
Nerviano Medical Sciences S.r.l. 18
Sanofi 19
Recurrent Malignant Glioma - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Target 21
Assessment by Mechanism of Action 23
Assessment by Route of Administration 25
Assessment by Molecule Type 27
Drug Profiles 29
cabazitaxel - Drug Profile 29

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on Blogger at: http://latestmedicalrelatedresearchreport.blogspot.in/

Comments

Popular posts from this blog

Research of Dental Burs Market in United States : Overview, Size, Share and Trends 2017

Global Technetium-99m Industry : Key Trends, Challenges and Standardization 2016-2024

During the Period 2017-2021, Global Vagus Nerve Stimulation Market to Grow at a CAGR of 9.63%